These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29384052)

  • 1. Repurposing N,N-Dimethylacetamide (DMA), a Pharmaceutical Excipient, as a Prototype Novel Anti-inflammatory Agent for the Prevention and/or Treatment of Preterm Birth.
    Gorasiya S; Mushi J; Pekson R; Yoganathan S; Reznik SE
    Curr Pharm Des; 2018; 24(9):989-992. PubMed ID: 29384052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigating the Et-1/SphK/S1P Pathway as a Novel Approach for the Prevention of Inflammation-Induced Preterm Birth.
    Giusto K; Ashby CR
    Curr Pharm Des; 2018; 24(9):983-988. PubMed ID: 29384055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N,N-Dimethylformamide Delays LPS-Induced Preterm Birth in a Murine Model by Suppressing the Inflammatory Response.
    Wei ZH; Salami OO; Koya J; Munnangi S; Pekson R; Ashby CR; Reznik SE
    Reprod Sci; 2022 Oct; 29(10):2894-2907. PubMed ID: 35349119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N,N-dimethylacetamide regulates the proinflammatory response associated with endotoxin and prevents preterm birth.
    Sundaram S; Ashby CR; Pekson R; Sampat V; Sitapara R; Mantell L; Chen CH; Yen H; Abhichandani K; Munnangi S; Khadtare N; Stephani RA; Reznik SE
    Am J Pathol; 2013 Aug; 183(2):422-30. PubMed ID: 23770347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New hope for prevention of preterm delivery.
    Roberts DJ
    Am J Pathol; 2013 Aug; 183(2):330-2. PubMed ID: 23810739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA-Approved Excipient N, N-Dimethylacetamide Attenuates Inflammatory Bowel Disease in
    Koya JB; Shen T; Lu G; Gauthier A; Mantell L; Ashby CR; Reznik SE
    Fortune J Health Sci; 2022; 5():499-509. PubMed ID: 37886658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised trial to compare 200 mg micronised progesterone effervescent vaginal tablet daily with 250 mg intramuscular 17 alpha hydroxy progesterone caproate weekly for prevention of recurrent preterm birth.
    Shambhavi S; Bagga R; Bansal P; Kalra J; Kumar P
    J Obstet Gynaecol; 2018 Aug; 38(6):800-806. PubMed ID: 29557230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic PreImplantation Factor (sPIF) reduces inflammation and prevents preterm birth.
    Spinelli M; Boucard C; Di Nicuolo F; Haesler V; Castellani R; Pontecorvi A; Scambia G; Granieri C; Barnea ER; Surbek D; Mueller M; Di Simone N
    PLoS One; 2020; 15(6):e0232493. PubMed ID: 32511256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of infection-mediated preterm birth by administration of broad spectrum chemokine inhibitor in mice.
    Shynlova O; Dorogin A; Li Y; Lye S
    J Cell Mol Med; 2014 Sep; 18(9):1816-29. PubMed ID: 24894878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N,N Dimethylacetamide a drug excipient that acts as bromodomain ligand for osteoporosis treatment.
    Ghayor C; Gjoksi B; Dong J; Siegenthaler B; Caflisch A; Weber FE
    Sci Rep; 2017 Feb; 7():42108. PubMed ID: 28176838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probiotic Lactobacillus kefiri prevents endotoxin-induced preterm birth and stillbirth in mice.
    Silvia Ventimiglia M; Jimena Valeff N; Pozo Albán M; Manuel Paturlanne J; Juriol L; Quadrana F; Cecotti M; Malamud M; Javier Dibo M; de Los Ángeles Serradell M; Jensen F
    Reproduction; 2021 May; 161(6):657-667. PubMed ID: 33835045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preterm birth: Inflammation, fetal injury and treatment strategies.
    Boyle AK; Rinaldi SF; Norman JE; Stock SJ
    J Reprod Immunol; 2017 Feb; 119():62-66. PubMed ID: 28122664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Noncompetitive IL-1 Receptor-Biased Ligand Prevents Infection- and Inflammation-Induced Preterm Birth.
    Nadeau-Vallée M; Quiniou C; Palacios J; Hou X; Erfani A; Madaan A; Sanchez M; Leimert K; Boudreault A; Duhamel F; Rivera JC; Zhu T; Noueihed B; Robertson SA; Ni X; Olson DM; Lubell W; Girard S; Chemtob S
    J Immunol; 2015 Oct; 195(7):3402-15. PubMed ID: 26304990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and risk factors of preterm births in a tertiary center in Lagos, Nigeria.
    Butali A; Ezeaka C; Ekhaguere O; Weathers N; Ladd J; Fajolu I; Esezobor C; Makwe C; Odusanya B; Anorlu R; Adeyemo W; Iroha E; Egri-Okwaji M; Adejumo P; Oyeneyin L; Abiodun M; Badejoko B; Ryckman K
    Pan Afr Med J; 2016; 24():1. PubMed ID: 27583065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone for preterm birth prevention: an evolving intervention.
    Tita AT; Rouse DJ
    Am J Obstet Gynecol; 2009 Mar; 200(3):219-24. PubMed ID: 19254577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Cervical Cerclage and Vaginal Progesterone in the Treatment of Cervical Incompetence with/without Preterm Birth History.
    Wang SW; Ma LL; Huang S; Liang L; Zhang JR
    Chin Med J (Engl); 2016 Nov; 129(22):2670-2675. PubMed ID: 27823998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indomethacin administration at the time of ultrasound-indicated cerclage: is there an association with a reduction in spontaneous preterm birth?
    Visintine J; Airoldi J; Berghella V
    Am J Obstet Gynecol; 2008 Jun; 198(6):643.e1-3. PubMed ID: 18221923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dental Infection of Porphyromonas gingivalis Induces Preterm Birth in Mice.
    Ao M; Miyauchi M; Furusho H; Inubushi T; Kitagawa M; Nagasaki A; Sakamoto S; Kozai K; Takata T
    PLoS One; 2015; 10(8):e0137249. PubMed ID: 26322971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusobacterium nucleatum induces fetal death in mice via stimulation of TLR4-mediated placental inflammatory response.
    Liu H; Redline RW; Han YW
    J Immunol; 2007 Aug; 179(4):2501-8. PubMed ID: 17675512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the putative novel selective ETA-receptor antagonist HJP272, a 1,3,6-trisubstituted-2-carboxy-quinol-4-one, on infection-mediated premature delivery.
    Olgun N; Patel HJ; Stephani R; Wang W; Yen H; Reznik SE
    Can J Physiol Pharmacol; 2008 Aug; 86(8):571-5. PubMed ID: 18758506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.